Updated:
Yuanhe Fund
Yuanhe Fund operates as a private equity manager linking early-stage venture origination to China’s provincial industrial policy.
Yuanhe Fund
Yuanhe Fund operates as a private equity manager linking early-stage venture origination to China’s provincial industrial policy. The firm targets six verticals — new energy, new materials, biomedicine, intelligent manufacturing, military-aerospace, and information technology — positioning its portfolio companies within the supply chains of state-directed industrial modernization. Strategy spans seed and start-up through growth equity, with the firm acting primarily as a direct investor. Deployment concentrates on mainland China, and the portfolio reveals an emphasis on hard-tech businesses that manufacture physical components or operate regulated infrastructure. Confirmed positions include Shali Biotechnology, which develops cell therapies and was named to the 2026 China Future Unicorn TOP100 list; Shanghai Junyi Industrial Automation, whose robotics-application engineering unit earned a 2026 National Worker Pioneer Award; and Saiying Electronics, a power-semiconductor packaging components maker that listed on the Beijing Stock Exchange in April 2026 (per the firm, April 2026). Yuanhe also participates in fund commitments, as illustrated by its limited-partner role in the vehicle that backed Saiying Electronics. Team size and aggregate deployment figures remain undisclosed. The firm maintains its sole office in Yantai, a port city in Shandong province with a dense cluster of petrochemical, automotive, and electronics manufacturers. The operational cadence visible through public announcements is event-driven and PR-aligned: in May 2026, the firm promoted an investor-protection education campaign tied to a national regulatory day, while its portfolio-company newsfeed logs exits, awards, and co-investor activity. It also reported that Sinopec Capital, through a hydrogen fund, completed a strategic nine-figure yuan investment in Yantai Wanhua Electronic Materials, an electronic specialty gas producer, in May 2026 (per the firm, May 2026). Yuanhe’s architecture differs from a pure financial sponsor in its explicit adoption of an industrial-policy investment logic. Rather than maximizing multiple on any single deal, it describes an approach built on long-duration holding periods and deep integration with local supply chains, treating portfolio construction as a form of regional industrial planning. This blurs the boundary between a venture capital firm and a state-aligned industrial accelerator, making the fund a conduit for capital seeking exposure to China’s manufacturing-upgrade theme while accepting the governance and exit-timing constraints that accompany such a mandate.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Yantai
Corporate office
Yantai, China
Sector focus
Frequently asked questions
How does Yuanhe Fund source its investment opportunities?
Yuanhe applies a sector-specialist model grounded in Yantai’s industrial base, using deep supply-chain mapping within its six target verticals to identify companies that can scale through integration with local manufacturers. Public announcements suggest the firm also co-invests alongside state-backed strategic investors — in May 2026 it reported that Sinopec Capital invested in portfolio-adjacent company Yantai Wanhua Electronic Materials, indicating connectivity to state-directed capital (per the firm, May 2026). This sourcing pattern produces deal flow that is concentrated in the Bohai economic rim and adjacent advanced-manufacturing clusters.
Does Yuanhe Fund participate in fund commitments or only direct investments?
Yuanhe engages in both direct equity investments and limited-partner commitments. The firm disclosed that it accessed Saiying Electronics, which listed on the Beijing Stock Exchange in April 2026, through a fund in which it was a participant — indicating a fund-of-funds or parallel-vehicle sleeve alongside its direct book (per the firm, April 2026). This dual approach allows the firm to back managers targeting its verticals while maintaining the ability to lead or co-lead direct rounds.
What investment stages does Yuanhe Fund typically target?
The firm operates across early-stage, seed, start-up, and growth stages, spanning venture and expansion capital. Its portfolio disclosures show the full lifecycle: from early-stage biomedical companies like Shali Biotechnology to later-stage industrial companies like Shanghai Junyi Industrial Automation and pre-IPO power-semiconductor manufacturer Saiying Electronics. The stage flexibility is consistent with a model that prioritizes sector alignment over stage rigidity.
Which sectors does Yuanhe Fund explicitly avoid?
Yuanhe does not publish a formal exclusion list, but its stated six focuses — new energy, new materials, biomedicine, intelligent manufacturing, military-aerospace, and information technology — define a hard-tech mandate. Consumer internet, platform-marketplace businesses, and pure software-as-a-service models are absent from its public portfolio and communications, making them effectively outside the investment perimeter. The firm's industrial-policy posture makes regulated or consumer-facing sectors unlikely targets.
How is Yuanhe Fund governed and who makes investment decisions?
Yuanhe does not publicly disclose the names or backgrounds of its management team or investment committee members. The firm's website describes its team and culture only in general terms, and no LinkedIn presence provides supplementary detail. For an institutional allocator, governance and key-person risk remain unobservable from primary public sources (Altss research).
What is Yuanhe Fund’s track record with exits and liquidity events?
The most concrete exit signal is the April 2026 Beijing Stock Exchange listing of Saiying Electronics, a portfolio company accessed through one of the firm's fund commitments (per the firm, April 2026). Beyond this single disclosed public-market exit, track record data, distribution timelines, and net multiples are not publicly available. The firm’s communications focus on portfolio-company milestones rather than fund-level performance metrics.
Does Yuanhe Fund maintain philanthropic or non-investment structures?
No philanthropic foundation, donor-advised fund, or separately governed non-investment entity is disclosed on the firm’s website or in public records. The firm’s public-facing activity outside of investing is limited to regulatory-outreach campaigns — such as the investor-protection education initiative it promoted in May 2026 — which align with regulatory compliance rather than a distinct philanthropic mission.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: